1. Using Healthcare Claims Data for Outcomes Research and Pharmacoeconomic Analyses

   • Howard G. Birnbaum
   • Pierre Y. Cremieux
   • Laura Venditti

   Current Opinion 22 September 2012 Pages: 1 - 8

2. The Pharmacoeconomics of Hormone Replacement Therapy

   • David J. Torgerson
   • David M. Reid

   Review Article 22 September 2012 Pages: 9 - 16

3. Benefit Valuation in Economic Evaluation of Cancer Therapies

   • Jackie Brown
   • Mark Sculpher

   Review Article 22 September 2012 Pages: 17 - 31

4. Measuring Sensitivity in Pharmacoeconomic Studies

   • Mark J. C. Nuijten

   Original Research Article 22 September 2012 Pages: 33 - 41

5. Economic Analysis of Carboplatin Versus Cisplatin in Lung and Ovarian Cancer

   • Zeba M. Khan
   • Karen L. Rascati
   • Jim M. Koeller

   Original Research Article 22 September 2012 Pages: 43 - 57

6. Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson’s Disease

   • Claude LePen
   • Suzanne Wait
   • Marc Ziégler

   Original Research Article 22 September 2012 Pages: 59 - 69

7. Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS

   • Anita Rachlis
   • Fiona Smaill
   • Amy Jones

   Original Research Article 22 September 2012 Pages: 71 - 84

8. Diclofenac/Misoprostol

   • Greg L. Plosker
   • Harriet M. Lamb

   Adis Formulary Perspective 22 September 2012 Pages: 85 - 98

9. Donepezil

   • Rachel H. Foster
   • Greg L. Plosker

   Adis Formulary Perspective 22 September 2012 Pages: 99 - 114